From GenomeWeb
NEW YORK – 10x Genomics is looking to raise up to $100 million in an initial public offering, according to documents filed Monday with the US Securities and Exchange Commission.
The single-cell sequencing firm did not disclose an expected share price range but said in a form S-1 that it plans to trade on the Nasdaq under ticker symbol “TXG.”
Related Posts
From GenomeWeb
NEW YORK – 10x Genomics is looking to raise up to $100 million in an initial public offering, according to documents filed Monday with the US Securities and Exchange Commission.
The single-cell sequencing firm did not disclose an expected share price range but said in a form S-1 that it plans to trade on the Nasdaq under ticker symbol “TXG.”
Related Posts
Recent Posts
New method allows scientists to follow gene activity over time in the same cells
Single-cell and single-embryo RNA sequencing
RNA sequencing reveals functional chimeric mRNAs in mammalian immunity
Deep learning improves microRNA target prediction from sequence
New Johns Hopkins Study Identifies Pervasive RT-qPCR Artifact in CRISPR Knockdown Studies and How UltraMarathonRT® Solves It
Atlas of the brain’s striatum could guide researchers to new drug treatments
RNA-Seq Products & Services
Stay Connected